• Bulletin du cancer · Aug 2002

    Review

    [Gemcitabine and breast cancer].

    • Benjamin Besse and Jean-Philippe Spano.
    • Département de médecine, Institut Gustave-Roussy, 94805 Villejuif.
    • Bull Cancer. 2002 Aug 1; 89 Spec No: S107-14.

    AbstractGemcitabine has demonstrated a good efficacy in number of tumor types. Thanks to its favourable toxicity profile, gemcitabine can be used in combination with a number of drugs. Single agent gemcitabine and gemcitabine-based combinations have been evaluated in metastatic breast cancer. Some of these combinations, such as gemcitabine-vinorelbine, seem highly efficacious in patients with taxane and/or anthracycline refractory disease. Other combinations such as gemcitabine-anthracycline-taxane regimens were found to be highly effective in the neoadjuvant setting or as first line treatment for metastatic breast cancer. Some of the combinations tested deserve further evaluation in phase III trials. Several phase III trials are in progress in Europe and in the USA. Final judgment on the contribution of gemcitabine will not be made until the results of these further studies become available.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…